Navigation Links
Baxter Adds Recombinant Protein to Specialty Therapeutics Portfolio
Date:10/16/2007

eurological abnormalities and kidney failure, TTP may be life-threatening. Currently, there are no treatments available, but a technique known as "plasma exchange," a process during which blood plasma is collected and exchanged, is used to normalize platelet counts and manage disease symptoms.

About Baxter

Baxter International Inc., through its subsidiaries, assists healthcare professionals and their patients with treatment of complex medical conditions, including hemophilia, immune disorders, cancer, infectious diseases, kidney disease, trauma and other indications. The company applies its expertise in medical devices, pharmaceuticals and biotechnology to make a meaningful difference in patients' lives.

About Kaketsuken

Kaketsuken is a Juridical Foundation which researches, develops, manufactures and supplies biological products such as vaccines for humans and animals, and blood plasma derivatives, based in Kumamoto, Japan. The foundation has pursued the preventive medicine fields of microbiology, immunology and serology, towards the improvement of health and hygiene, and presently is a leading company in these fields of human vaccines, animal vaccines, and blood plasma derivatives respectively in the Japanese market. Kaketsuken is also developing therapeutic antibodies. For further information about Kaketsuken, please visit the company's web site at: http://www.kaketsuken.or.jp/eng.

This release includes forward-looking statements concerning the development of a recombinant form of ADAMTS13. The statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements: satisfaction of regulatory and other requirements for timely commencement of clinical trials; additional results, including results in humans, demonstrating the safety and efficacy of the product;
'/>"/>

SOURCE Baxter International Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Expression and Purification of Recombinant Proteins That Have Native Amino Acid Sequence
2. Proteinase K, Recombinant, PCR Grade: the Ideal Tool for Template Preparations
3. Recombinant HIV Reverse Transcriptase
4. Purification of Recombinant Flavonone 3beta-Hydroxylase Using Bio-Scale CHT5-1 Hydroxyapatite Column
5. Preparative SDS-PAGE Electrophoresis of a Recombinant Epstein-Barr Virus Encoded Protein and Its Application in Serodiagnostic Test Systems, Rev C
6. Cell lines expressing recombinant aequorin and a G-protein coupled receptor for functional screening
7. Luciferase Reporter Gene Cells and Recombinant Luciferase Dilutions Studied with the CLIPR Luciferase Assay Kit and the LMax Microplate Luminometer (MaxLine Application Note #38)
8. A New C-Terminal GST Vector for Protein Production in S. pombe
9. New Mammalian Two-Hybrid System Detects Protein-Protein Interactions
10. Antibodies for Studying NMDA Receptor Protein Expression and Synapse-Specific Immunolabeling
11. Simple, Sensitive, and Rapid Detection of FLAG -Tagged Fusion Proteins
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... -- BioEnterprise today announced that Northeast Ohio ... billion in growth funding during the past 13 years.  ... state – including the Ohio Third Frontier - and ... been raised in the past five years. ... BioEnterprise Midwest Healthcare Growth Capital  Report.   ...
(Date:2/26/2015)... 26, 2015 Innovation is more ... from unexpected parts of the world and transforming ... agriculture to manufacturing to health care, disruption is ... realities and socio-political trends shake the foundations of ... ingredient for CEOs to survive the next wave ...
(Date:2/26/2015)... 2015  Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), ... technologies are used to develop, manufacture and sell ... chemical, biopharmaceutical and industrial enzyme industries, announced today ... year ending December 31, 2014 after market close ... a conference call that day at 5:00 p.m. ...
(Date:2/26/2015)... Tauriga Sciences, Inc. (OTCQB: TAUG) ("Tauriga" or the ... the natural wellness sector and in developing a proprietary ... will be featured at the SEC Compliance sponsor booth ... Annual Growth Stock Conference on March 8-11 th ... Drive, Dana Point , California.  One ...
Breaking Biology Technology:More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 2More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 3More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 4One Million Acts of Innovation Canada Creates Partnership with The Economist Events’ Innovation Forum 2Dyadic International To Announce Fourth Quarter 2014 Financial Results And Host Conference Call On Wednesday, March 11, 2015 2Dyadic International To Announce Fourth Quarter 2014 Financial Results And Host Conference Call On Wednesday, March 11, 2015 3SEC Compliance Featuring Products From Tauriga Sciences, Inc. at ROTH Capital Conference 2SEC Compliance Featuring Products From Tauriga Sciences, Inc. at ROTH Capital Conference 3SEC Compliance Featuring Products From Tauriga Sciences, Inc. at ROTH Capital Conference 4
... April 29, 2011 Keryx Biopharmaceuticals, Inc. (NASDAQ: ... acquisition, development and commercialization of medically important pharmaceutical products ... "Company"), today announced its results for the first quarter ... 2011, the Company had cash, cash equivalents and investment ...
... Frost & Sullivan Europe New Product Innovation Award in ... its state-of-the-art, high precision Novelda Impulse Radar transceiver - ... transceiver is a cutting-edge radar transceiver that incorporates extremely ... penetration capabilities," remarks Frost & Sullivan Research Analyst V. ...
... 2011 Keryx Biopharmaceuticals (Nasdaq: KERX ) ... short-term clinical trial of Zerenex ™ (ferric citrate) ... patients on dialysis.  The Zerenex data was presented earlier ... being held in Las Vegas, Nevada, in an oral ...
Cached Biology Technology:Keryx Biopharmaceuticals, Inc. Announces First Quarter 2011 Financial Results 2Keryx Biopharmaceuticals, Inc. Announces First Quarter 2011 Financial Results 3Keryx Biopharmaceuticals, Inc. Announces First Quarter 2011 Financial Results 4Frost & Sullivan Award Acknowledges Novelda's Cutting-Edge Product Innovation 2Frost & Sullivan Award Acknowledges Novelda's Cutting-Edge Product Innovation 3Frost & Sullivan Award Acknowledges Novelda's Cutting-Edge Product Innovation 4Keryx Biopharmaceuticals Announces Positive Final Data from Zerenex™ Short-Term Phase 3 Study 2Keryx Biopharmaceuticals Announces Positive Final Data from Zerenex™ Short-Term Phase 3 Study 3Keryx Biopharmaceuticals Announces Positive Final Data from Zerenex™ Short-Term Phase 3 Study 4
(Date:1/22/2015)... Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ON), is pleased to inform ... State of Washington,s Department of Licensing, in the ... issuance system for driver,s licenses and identification cards to its ... development will start in January 2015, with enrollment and card ...
(Date:1/22/2015)... 2015  A man-made form of insulin delivered by nasal ... in adults with mild cognitive impairment and Alzheimer,s disease ... at Wake Forest Baptist Medical Center. The ... cognitive impairment (MCI) or mild to moderate Alzheimer,s dementia ...
(Date:1/22/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/wxdglm/global_wearable ... "Global Wearable Technologies Market and Applications, Opportunities, Industry ... Forecast 2014-2020" report to their offering. ... that can be worn on the user,s body ...
Breaking Biology News(10 mins):Valid USA Signs Contract For Washington Driver's License Issuance 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 2
... A study of 36 Spanish honeys from different floral ... honeydew have greater antioxidant properties than those produced by ... this month’s edition of the Journal of the Science ... important ingredients of many foods, and keenly sought in ...
... people will gladly remove excess body fat to improve their ... potential to repair defects and heal injuries in the body. ... Oslo in Norway has identified certain chemical marks that allow ... stem cells in liposuctioned fat, are best at regenerating tissue. ...
... Research Specialist II, and Linheng Li, Ph.D., Associate Investigator, are ... that clarifies how normal stem cells become cancer stem cells ... tumors. , The paper, "PTEN-deficient intestinal stem cells initiate ... on January 21. , The theory that cancer stem ...
Cached Biology News:Liposuctioned fat stem cells to repair bodies 2Linheng Li Lab documents the development of cancer stem cells 2
... system for detection of very low level ... Equipped with an extreme sensitive camera to ... plants in tumor research, infectious disease research, ... NightOWL is the only imager with a ...
... Analyzer and Sorter) large particle flow cytometers ... flow cytometry to applications that were not ... and sorting. Our instruments are based ... cytometers, but are designed to accommodate much ...
Mouse monoclonal antibody raised against a full length recombinant LDB3. NCBI Entrez Gene ID = LDB3...
...
Biology Products: